Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06020248 · ClinicalTrials.gov registry record · NA
Melanin and Dermal Uptake of Thirdhand Cigarette Smoke
A NA study, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06020248: Recruiting NA study, sponsored by University of California, San Francisco.
NCT06020248 is a NA study that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06020248, a NA study, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a pilot study of the effects of dermal melanin on dermal uptake and retention of nicotine. The initial hypothesis is that higher levels of dermal melanin will correlate with lower uptake and longer retention of nicotine in the skin and body.
Primary Outcome
The study will measure concentration of nicotine in the blood before and after the dermal exposure to nicotine.
Interventions
- OTHER Wear clothing that has been exposed to cigarette smoke for 3 hours.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2026-11 |
| Phase | NA |
What NCT06020248 shows while recruiting
NCT06020248 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Wear clothing that has been exposed to cigarette smoke for 3 hours. is the first listed.
NCT06020248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06020248 about?
NCT06020248 is a clinical study titled "Melanin and Dermal Uptake of Thirdhand Cigarette Smoke". This is a pilot study of the effects of dermal melanin on dermal uptake and retention of nicotine. The initial hypothesis is that higher levels of dermal melanin will correlate with lower uptake and longer retention of nicotine in the skin and body.
What is the current status of trial NCT06020248?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-09-01. Estimated completion is 2026-11.
What interventions are being tested in trial NCT06020248?
The interventions under investigation include: Wear clothing that has been exposed to cigarette smoke for 3 hours. (OTHER).
Who is sponsoring clinical trial NCT06020248?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06020248's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI